Sangam: A Confluence of Knowledge Streams

STAT6, a novel regulator of beta cell viability, is reduced in islets of patients with recent-onset Type 1 diabetes.

Show simple item record

dc.creator Russell, Mark
dc.creator Taniguchi, K
dc.creator Richardson, Sarah
dc.creator Morgan, Noel
dc.date 2016-03-21T13:16:02Z
dc.date 2016-03-21T13:16:02Z
dc.date 2016-03
dc.date.accessioned 2023-02-17T19:48:02Z
dc.date.available 2023-02-17T19:48:02Z
dc.identifier STAT6, a novel regulator of beta cell viability, is reduced in islets of patients with recent-onset Type 1 diabetes. in: Basic and clinical science posters: beta cells, islets and stem cells 2016, 33:37 Diabetic Medicine
dc.identifier 07423071
dc.identifier 10.1111/dme.2_13048
dc.identifier http://hdl.handle.net/11287/602312
dc.identifier Diabetic Medicine
dc.identifier.uri http://localhost:8080/xmlui/handle/CUHPOERS/241999
dc.language en
dc.publisher Wiley
dc.relation http://doi.wiley.com/10.1111/dme.2_13048
dc.rights Archived with thanks to Diabetic Medicine
dc.subject Wessex Classification Subject Headings::Endocrinology::Diabetes
dc.title STAT6, a novel regulator of beta cell viability, is reduced in islets of patients with recent-onset Type 1 diabetes.
dc.title Basic and clinical science posters: beta cells, islets and stem cells
dc.type Poster
dc.type Published


Files in this item

Files Size Format View

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse